The Sunrest Lifescience IPO has begun on 07-Nov-2023. It will close on 09-Nov-2023. The Total IPO Size is 10.85 Crores. The company set its IPO price is 84 Rs Per Share. Basically, There are two basic categories in Sunrest Lifescience IPO Subscription 1) Other 2) Retail Individual Investors (RIIs)
Sunrest Lifescience is established in 2017.
Sunrest Lifescience is offers a diverse range of healthcare and personal care products.
They deal in Capsules, Tablets, Syrup, Ointment, Gel, Mouth Wash, Solution, Suspension, Dry Powders and Toothpaste. Our product portfolio comprises of vide range of drugs like Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs,
Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory. The company have 18 Registered Trademarks for 32 products.
The Company is engaged in the marketing of OTC generic pharmaceutical products in the domestic market. The company offer range of pharmaceutical products manufactured by third party manufacturers. The company operate in different States of India such as Maharashtra, Gujarat, Madhya Pradesh, Orissa and Rajasthan.
Check :- Upcoming SME IPO 2023
Sunrest Lifescience IPO Promotor Holding
Mr. Nikhilkumar Y Thakkar, Mr. Amitbhai Shambhulal Thakkar, Mr. Bhagyesh Kiritbhai Parekh and Mr. Bharatkumar V Thakkar are the promoters of the company.
Sunrest Lifescience IPO Date, Details & Price Band
IPO Opening Dates | 07-November-2023 |
IPO Closing Dates | 09-November-2023 |
Price Band | 84 Rs |
Fresh issue | 10.85 Crore |
Total IPO size | 10.85 Crore |
Minimum bid (lot size) | 1600 Shares |
Face Value | 10 INR Per Share |
Listing On | NSE SME |
Sunrest Lifescience IPO Market Lot
The Sunrest Lifescience IPO minimum market lot is 1600 shares With 1,34,400 ₹ Amount per application.
Lot | No of Shares | Amount | |
Minimum | 1 | 1600 | 1,34,400 Rs |
Maximum | 1 | 1600 | 1,34,400 Rs |
S-HNI (Min) | 2 | 3200 | 2,68,800 Rs |
Restated Financial Record of the three year (Amt. in Lakhs)
Total Assets | Total Revenue | Profit After Tax | |
31-Mar-21 | 948.15 | 1,694.91 | 16.55 |
31-Mar-22 | 1,301.97 | 2,690.99 | 77.71 |
31-Mar-23 | 1,671.37 | 2,467.05 | 204.31 |
Sunrest Lifescience IPO GMP Grey Market Premium
Sunrest Lifescience IPO GMP Grey market premium has been started today. Check Latest Sunrest Lifescience IPO GMP Grey market premium, Kostak Rates and Subject to Sauda Price here.
Sunrest Lifescience IPO Prospectus
DRHP | Download |
RHP | Download |
Sunrest Lifescience IPO Reviews
AngelOne – Update Soon
Choice Broking – Update Soon
Prabhudas Lilladher – Update Soon
Sunrest Lifescience IPO Form Download
Sunrest Lifescience IPO is available on NSE Website as well as on our Portal. Please click here Sunrest Lifescience IPO form Download.
Sunrest Lifescience IPO Allotment Date & Details
Allotment Date | 15-November-2023 |
Initiation of refunds | 16-November-2023 |
Transfer of shares to Demat accounts | 17-November-2023 |
Listing Date | 20-November-2023 |
Check Allotment Status | Click here |
Registrar of Sunrest Lifescience IPO
Skyline Financial Services Private Limited
CIN – U74899DL1995PTC071324
D-153/ A, First Floor, Okhla Industrial Area,
Phase – I, New Delhi – 110020
Telephone – +91 1126812682
E-mail id: [email protected]
Investor Grievance Email: [email protected]
Contact person: Mr. Anuj Rana
Website: http://www.skylinerta.com/; SEBI Regn. No.: INR000003241
Sunrest Lifescience Contact Details
Sunrest Lifescience Limited
FF-41, Ajay Tenament-6,
Near Canal Near Ritanagar, Bus Stand Vastral Road,
Ahmedabad-382415
Phone: +91-079 – 29918245
Email: [email protected]
Website: https://sunrestlifescience.com/
Sunrest Lifescience IPO Lead Managers
Mark Corporate Advisors Private Limited
CIN – U67190MH2008PTC181996
404/1, The Summit Business Bay, Sant Janabai Road (Service Lane),
Off W. E. Highway, Vile Parle (East), Mumbai-400 057. Maharashtra, India
Tel. No.: +91 22 2612 3208
Email ID: [email protected]
Investor Grievance Email ID: [email protected]
Contact Person: Mr. Niraj Kothari
Website: www.markcorporateadvisors.com; SEBI Regn. No.: INM000012128